Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2016

Dec 19, 2016

30681_dirs_2016-12-19_907742af-36cf-4b9e-aebc-6b82759d2096.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-12-15

Reporting Person: Tammenoms Bakker Juliet (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-12-15 Common Stock G 70671 $0.00 Disposed 133539 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10740720 Indirect
Common Stock 215282 Indirect

Footnotes

F1: Reflects holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Partners, L.P. ("LCA"). Ms. Bakker is a managing member of Longitude Capital Partners, LLC, the sole general partner of LVP and LCA. Ms. Bakker disclaims beneficial ownership of the securities of the Issuer held of record by LVP and LCA, except to the extent of her pecuniary interest therein.